NO20056070L - Anti artrittkombinasjoner - Google Patents

Anti artrittkombinasjoner

Info

Publication number
NO20056070L
NO20056070L NO20056070A NO20056070A NO20056070L NO 20056070 L NO20056070 L NO 20056070L NO 20056070 A NO20056070 A NO 20056070A NO 20056070 A NO20056070 A NO 20056070A NO 20056070 L NO20056070 L NO 20056070L
Authority
NO
Norway
Prior art keywords
combinations
arthritis
anti arthritis
inhibition
therapy
Prior art date
Application number
NO20056070A
Other languages
English (en)
Norwegian (no)
Inventor
Heather Anne Harris
Damien P Quinn
Regina H Kurrasch
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of NO20056070L publication Critical patent/NO20056070L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A61K31/055—Phenols the aromatic ring being substituted by halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
NO20056070A 2003-05-21 2005-12-20 Anti artrittkombinasjoner NO20056070L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47238203P 2003-05-21 2003-05-21
PCT/US2004/016030 WO2004103365A1 (en) 2003-05-21 2004-05-20 Antiarthritic combinations

Publications (1)

Publication Number Publication Date
NO20056070L true NO20056070L (no) 2006-02-14

Family

ID=33476949

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20056070A NO20056070L (no) 2003-05-21 2005-12-20 Anti artrittkombinasjoner

Country Status (17)

Country Link
US (1) US20040248865A1 (pt)
EP (1) EP1631283A1 (pt)
JP (1) JP2007500223A (pt)
KR (1) KR20060013666A (pt)
CN (1) CN1791404A (pt)
AR (1) AR044428A1 (pt)
AU (1) AU2004240668A1 (pt)
BR (1) BRPI0411145A (pt)
CA (1) CA2524116A1 (pt)
CL (1) CL2004001186A1 (pt)
EC (1) ECSP056177A (pt)
MX (1) MXPA05012562A (pt)
NO (1) NO20056070L (pt)
RU (1) RU2005140041A (pt)
TW (1) TW200500065A (pt)
WO (1) WO2004103365A1 (pt)
ZA (1) ZA200509376B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006060542A2 (en) * 2004-12-02 2006-06-08 Wyeth Formulations of substituted benzoxazoles
US20060210644A1 (en) * 2004-12-16 2006-09-21 Bruce Levin Materials, methods, and devices for treatment of arthropathies and spondylopathies
JPWO2006104172A1 (ja) * 2005-03-29 2008-09-11 興和株式会社 関節リウマチの予防及び／又は治療薬
AR059574A1 (es) * 2006-02-14 2008-04-16 Wyeth Corp Formulaciones farmaceuticas acuosas de ligandos selectivos er-beta
RU2367430C1 (ru) * 2008-04-16 2009-09-20 Государственное учреждение Научно-исследовательский институт клинической иммунологии СО РАМН Способ прогноза эффективности лечения ревматоидного артрита симвастатином
WO2009131098A1 (ja) 2008-04-22 2009-10-29 富山化学工業株式会社 ベンゾフェノン誘導体またはその塩および免疫抑制剤を組み合わせて使用する方法ならびにこれらを含有する医薬組成物
CN102427822A (zh) * 2009-05-18 2012-04-25 香港大学 治疗炎症性关节炎的组合物和方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5362718A (en) * 1994-04-18 1994-11-08 American Home Products Corporation Rapamycin hydroxyesters
MXPA01002173A (es) * 1998-08-28 2003-07-14 Scios Inc Inhibidores de p38-alfa cinasa.
US6080580A (en) * 1998-10-05 2000-06-27 Isis Pharmaceuticals Inc. Antisense oligonucleotide modulation of tumor necrosis factor-α (TNF-α) expression
US6225311B1 (en) * 1999-01-27 2001-05-01 American Cyanamid Company Acetylenic α-amino acid-based sulfonamide hydroxamic acid tace inhibitors
US6541477B2 (en) * 1999-08-27 2003-04-01 Scios, Inc. Inhibitors of p38-a kinase
WO2002046168A1 (en) * 2000-12-07 2002-06-13 Astrazeneca Ab Therapeutic benzimidazole compounds
US6589980B2 (en) * 2001-05-17 2003-07-08 Wyeth Substituted 10,11-benzo[b]fluoren-10-ones as estrogenic agents
UA83620C2 (ru) * 2001-12-05 2008-08-11 Уайт Замещенные бензоксазолы и их аналоги как эстрогенные агенты
US6914074B2 (en) * 2001-12-13 2005-07-05 Wyeth Substituted phenyl naphthalenes as estrogenic agents

Also Published As

Publication number Publication date
WO2004103365A1 (en) 2004-12-02
CL2004001186A1 (es) 2005-04-15
CN1791404A (zh) 2006-06-21
JP2007500223A (ja) 2007-01-11
US20040248865A1 (en) 2004-12-09
BRPI0411145A (pt) 2006-07-11
AR044428A1 (es) 2005-09-14
CA2524116A1 (en) 2004-12-02
EP1631283A1 (en) 2006-03-08
RU2005140041A (ru) 2006-05-10
KR20060013666A (ko) 2006-02-13
TW200500065A (en) 2005-01-01
ECSP056177A (es) 2006-04-19
ZA200509376B (en) 2007-04-25
AU2004240668A1 (en) 2004-12-02
MXPA05012562A (es) 2006-04-18

Similar Documents

Publication Publication Date Title
NO20071926L (no) Anvendelse av en mTOR-inhibitor i behandling av uterint leioyom.
WO2006015263A3 (en) Lonidamine analogs
DK1894564T3 (da) Anvendelse af en IBAT inhibitor til behandling eller profylakse af konstipation
DE60332475D1 (de) Zusammensetzungen verwendbar für die hemmung von rock und anderen kinasen
MXPA06001134A (es) Inhibidores de la actividad de la proteina cinasa b.
NO20023050L (no) Fremgangsmåte samt anlegg for utf degree relse av fremgangsmåten
PL2269458T3 (pl) Mieszaniny zawierające strobiluryny i modulatory etylenu
BRPI0416268A (pt) composições de delta-9-thc e métodos para o tratamento de sintomas associados à esclerose múltipla
CL2007002384A1 (es) Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento de la psoriasis.
ATE448232T1 (de) Substituierte heterozyklen
PL1713503T3 (pl) Hamowanie czynnika B, alternatywny szlak dopełniacza i związane z tym sposoby
NL1025873A1 (nl) Doseringsvormen en wijzen van behandeling met vegfr-remmers.
FI20030893L (fi) Näppäimistö ja menetelmä sen valmistamiseksi
EP1863769A4 (en) HSP90 INHIBITORS, METHOD FOR THE PRODUCTION THEREOF AND THEIR APPLICATIONS
DE60305522D1 (de) Pharmazeutische zusammensetzung enthaltend tenatoprazol und einen entzündungshemmer
FR2886851B1 (fr) Composition a base d'une avermectine et de metronidazole notamment pour le traitement de la rosacee
ATE382040T1 (de) Acylaminothiazolderivate und ihre vewrendung als beta-amyloid inhibitoren
NO20056070L (no) Anti artrittkombinasjoner
EP1656671A4 (en) Spin coating apparatus and coated substrate manufactured using the same
WO2007059226A3 (en) Photoactivatable antimicrobial agents
DE60310092D1 (de) Gelförmiges wasch- und/oder vorbehandlungsmittel
HUP0203153A2 (hu) Kombinációs kemoterápia
IL173188A0 (en) Use of alcohol-oxyalkyates in the form of adjuvants for benzamidoxime gungicidal derivatives, appropriate agents and kits
NO20053903L (no) Nukleotidlipidesterderivater.
EP1601325A4 (en) ANTI-SENSE OLIGONUCLEOTIDES INHIBITING EXPRESSION OF HIF-1

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application